Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells.

Herbst-Kralovetz MM, Radtke AL, Lay MK, Hjelm BE, Bolick AN, Sarker SS, Atmar RL, Kingsley DH, Arntzen CJ, Estes MK, Nickerson CA.

Emerg Infect Dis. 2013 Mar;19(3):431-8. doi: 10.3201/eid1903.121029.

2.

A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge.

Phoolcharoen W, Dye JM, Kilbourne J, Piensook K, Pratt WD, Arntzen CJ, Chen Q, Mason HS, Herbst-Kralovetz MM.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20695-700. doi: 10.1073/pnas.1117715108. Epub 2011 Dec 5.

3.

Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.

Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, Ni Y, Arntzen CJ, Herbst-Kralovetz MM.

Vaccine. 2011 Jul 18;29(32):5221-31. doi: 10.1016/j.vaccine.2011.05.027. Epub 2011 Jun 2.

4.

Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.

Phoolcharoen W, Bhoo SH, Lai H, Ma J, Arntzen CJ, Chen Q, Mason HS.

Plant Biotechnol J. 2011 Sep;9(7):807-16. doi: 10.1111/j.1467-7652.2011.00593.x. Epub 2011 Feb 1.

5.

An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles.

Velasquez LS, Hjelm BE, Arntzen CJ, Herbst-Kralovetz MM.

Clin Vaccine Immunol. 2010 Dec;17(12):1850-8. doi: 10.1128/CVI.00230-10. Epub 2010 Oct 20.

6.

HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity.

Matoba N, Husk AS, Barnett BW, Pickel MM, Arntzen CJ, Montefiori DC, Takahashi A, Tanno K, Omura S, Cao H, Mooney JP, Hanson CV, Tanaka H.

PLoS One. 2010 Jun 15;5(6):e11143. doi: 10.1371/journal.pone.0011143.

7.

High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system.

Huang Z, Phoolcharoen W, Lai H, Piensook K, Cardineau G, Zeitlin L, Whaley KJ, Arntzen CJ, Mason HS, Chen Q.

Biotechnol Bioeng. 2010 May 1;106(1):9-17. doi: 10.1002/bit.22652.

8.

Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model.

Hjelm BE, Berta AN, Nickerson CA, Arntzen CJ, Herbst-Kralovetz MM.

Biol Reprod. 2010 Mar;82(3):617-27. doi: 10.1095/biolreprod.109.080408. Epub 2009 Dec 9.

9.

Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system.

Del Prete G, Santi L, Andrianaivoarimanana V, Amedei A, Domarle O, D' Elios MM, Arntzen CJ, Rahalison L, Mason HS.

Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):133-43.

PMID:
19309560
10.

Plant science. Using tobacco to treat cancer.

Arntzen CJ.

Science. 2008 Aug 22;321(5892):1052-3. doi: 10.1126/science.1163420. No abstract available.

PMID:
18719274
11.

An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles.

Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q, Mason HS.

Vaccine. 2008 Mar 28;26(15):1846-54. doi: 10.1016/j.vaccine.2008.01.053. Epub 2008 Feb 15.

12.

Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria.

Lee KY, Kim DH, Kang TJ, Kim J, Chung GH, Yoo HS, Arntzen CJ, Yang MS, Jang YS.

FEMS Immunol Med Microbiol. 2006 Dec;48(3):381-9. Epub 2006 Oct 20.

13.

Synthesis and assembly of Escherichia coli heat-labile enterotoxin B subunit in transgenic lettuce (Lactuca sativa).

Kim TG, Kim MY, Kim BG, Kang TJ, Kim YS, Jang YS, Arntzen CJ, Yang MS.

Protein Expr Purif. 2007 Jan;51(1):22-7. Epub 2006 Jul 15.

PMID:
16919472
14.

Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies.

Saldaña S, Esquivel Guadarrama F, Olivera Flores Tde J, Arias N, López S, Arias C, Ruiz-Medrano R, Mason H, Mor T, Richter L, Arntzen CJ, Gómez Lim MA.

Viral Immunol. 2006 Spring;19(1):42-53.

PMID:
16553549
15.

Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.

Huang Z, Santi L, LePore K, Kilbourne J, Arntzen CJ, Mason HS.

Vaccine. 2006 Mar 24;24(14):2506-13. Epub 2005 Dec 28.

PMID:
16417953
16.

Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.

Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS.

Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):861-6. Epub 2006 Jan 12.

17.

Challenges in creating a vaccine to prevent hepatitis E.

Maloney BJ, Takeda N, Suzaki Y, Ami Y, Li TC, Miyamura T, Arntzen CJ, Mason HS.

Vaccine. 2005 Mar 7;23(15):1870-4.

PMID:
15734058
18.

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses.

Huang Z, Elkin G, Maloney BJ, Beuhner N, Arntzen CJ, Thanavala Y, Mason HS.

Vaccine. 2005 Mar 7;23(15):1851-8.

PMID:
15734055
19.

Immunogenicity in humans of an edible vaccine for hepatitis B.

Thanavala Y, Mahoney M, Pal S, Scott A, Richter L, Natarajan N, Goodwin P, Arntzen CJ, Mason HS.

Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3378-82. Epub 2005 Feb 22.

20.

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

Matoba N, Magérus A, Geyer BC, Zhang Y, Muralidharan M, Alfsen A, Arntzen CJ, Bomsel M, Mor TS.

Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13584-9. Epub 2004 Sep 3.

21.

On risk and plant-based biopharmaceuticals.

Peterson RK, Arntzen CJ.

Trends Biotechnol. 2004 Feb;22(2):64-6.

PMID:
14757039
22.

Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana.

Rigano MM, Alvarez ML, Pinkhasov J, Jin Y, Sala F, Arntzen CJ, Walmsley AM.

Plant Cell Rep. 2004 Feb;22(7):502-8. Epub 2003 Oct 10.

PMID:
14551732
23.

GM crops: science, politics and communication.

Arntzen CJ, Coghlan A, Johnson B, Peacock J, Rodemeyer M.

Nat Rev Genet. 2003 Oct;4(10):839-43. Review.

PMID:
14526380
24.

Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies.

Smith ML, Richter L, Arntzen CJ, Shuler ML, Mason HS.

Vaccine. 2003 Sep 8;21(25-26):4011-21.

PMID:
12922138
25.

Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato.

Walmsley AM, Alvarez ML, Jin Y, Kirk DD, Lee SM, Pinkhasov J, Rigano MM, Arntzen CJ, Mason HS.

Plant Cell Rep. 2003 Jun;21(10):1020-6. Epub 2003 Apr 11.

PMID:
12835913
26.

Plant cell factories and mucosal vaccines.

Walmsley AM, Arntzen CJ.

Curr Opin Biotechnol. 2003 Apr;14(2):145-50. Review.

PMID:
12732315
27.

Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites.

Rigano MM, Sala F, Arntzen CJ, Walmsley AM.

Vaccine. 2003 Jan 30;21(7-8):809-11. Review.

PMID:
12531365
28.

Metabolomics of plant saponins: bioprospecting triterpene glycoside diversity with respect to mammalian cell targets.

Joshi L, Van Eck JM, Mayo K, Di Silvestro R, Blake Nieto ME, Ganapathi T, Haridas V, Gutterman JU, Arntzen CJ.

OMICS. 2002;6(3):235-46.

PMID:
12427275
29.

Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine.

Mason HS, Warzecha H, Mor T, Arntzen CJ.

Trends Mol Med. 2002 Jul;8(7):324-9. Review.

PMID:
12114111
30.

Expression of recombinant human acetylcholinesterase in transgenic tomato plants.

Mor TS, Sternfeld M, Soreq H, Arntzen CJ, Mason HS.

Biotechnol Bioeng. 2001 Nov 5;75(3):259-66.

PMID:
11590598
32.

Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model.

Hanausek M, Ganesh P, Walaszek Z, Arntzen CJ, Slaga TJ, Gutterman JU.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11551-6.

33.

Oral immunization with hepatitis B surface antigen expressed in transgenic plants.

Kong Q, Richter L, Yang YF, Arntzen CJ, Mason HS, Thanavala Y.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11539-44. Epub 2001 Sep 11.

34.

Avicins: triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation.

Haridas V, Higuchi M, Jayatilake GS, Bailey D, Mujoo K, Blake ME, Arntzen CJ, Gutterman JU.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5821-6.

35.

Plants for delivery of edible vaccines.

Walmsley AM, Arntzen CJ.

Curr Opin Biotechnol. 2000 Apr;11(2):126-9. Review.

PMID:
10753769
36.

Agrobacterium -mediated transformation of embryogenic cell suspensions of the banana cultivar Rasthali (AAB).

Ganapathi TR, Higgs NS, Balint-Kurti PJ, Arntzen CJ, May GD, Van Eck JM.

Plant Cell Rep. 2001 Feb;20(2):157-162. doi: 10.1007/s002990000287.

PMID:
30759903
37.

Production of hepatitis B surface antigen in transgenic plants for oral immunization.

Richter LJ, Thanavala Y, Arntzen CJ, Mason HS.

Nat Biotechnol. 2000 Nov;18(11):1167-71.

PMID:
11062435
38.

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes.

Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ.

J Infect Dis. 2000 Jul;182(1):302-5. Epub 2000 Jul 6.

PMID:
10882612
39.

A tool for functional plant genomics: chimeric RNA/DNA oligonucleotides cause in vivo gene-specific mutations.

Beetham PR, Kipp PB, Sawycky XL, Arntzen CJ, May GD.

Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8774-8.

40.
41.

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.

Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ.

Nat Med. 1998 May;4(5):607-9.

PMID:
9585236
42.

Pharmaceutical foodstuffs--oral immunization with transgenic plants.

Arntzen CJ.

Nat Med. 1998 May;4(5 Suppl):502-3. No abstract available.

PMID:
9585197
43.

Some issues for the biosafety protocol.

Miller HI, Arntzen CJ, Beachy RN, Cook RJ, Huttner SL, Kennedy D, Qualset CO, Raven PH, Vidaver AK.

Nature. 1998 Mar 19;392(6673):221. No abstract available.

PMID:
9521312
44.

The abundant 31-kilodalton banana pulp protein is homologous to class-III acidic chitinases.

Clendennen SK, López-Gómez R, Gómez-Lim M, Arntzen CJ, May GD.

Phytochemistry. 1998 Feb;47(4):613-9.

PMID:
9461677
45.

High-tech herbal medicine: plant-based vaccines.

Arntzen CJ.

Nat Biotechnol. 1997 Mar;15(3):221-2. No abstract available.

PMID:
9062916
46.

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5335-40.

47.

Transgenic Plants Created for Oral Immunization Against Diarrheal Diseases.

Richter L, Mason HS, Arntzen CJ.

J Travel Med. 1996 Mar 1;3(1):52-56.

48.

Transgenic plants as vaccine production systems.

Mason HS, Arntzen CJ.

Trends Biotechnol. 1995 Sep;13(9):388-92. Review.

PMID:
7546570
49.

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

Haq TA, Mason HS, Clements JD, Arntzen CJ.

Science. 1995 May 5;268(5211):714-6.

PMID:
7732379
50.

Through the glass lightly.

Arntzen CJ.

Science. 1995 Mar 17;267(5204):1616. No abstract available.

PMID:
17808163

Supplemental Content

Loading ...
Support Center